medigraphic.com
ISSN 1561-302X (Print)

2021, Number 3

<< Back Next >>

Rev cubana med 2021; 60 (3)

Lymphocyte neutrophilic index in the prediction of type 4 myocardial infarction

Rodríguez BS, Véliz MPL, Tamargo BTO, Pérez YLM

Language: Spanish
References: 26
Page: 1-13
PDF size: 387.00 Kb.


ABSTRACT

Introduction: Type 4a myocardial infarction is a complication of percutaneous coronary intervention, which is associated with an inflammatory process. The lymphocyte neutrophilic index, as a marker of inflammation, could be included in your risk stratification.
Objectives: To assess the sensitivity, specificity, predictive values and the variation of the lymphocyte neutrophilic index in the prediction of type 4a myocardial infarction.
Methods: A prospective cohort investigation was carried in 184 patients who underwent percutaneous coronary intervention.
Results: For a value higher than and equal to 2.74, the index showed 72.0%, sensitivity, 74.8% specificity and 94.4% negative predictive value in the prediction of type 4a infarction. The variation of the index was an independent predictor of the complication p < 0.001.
Conclusions: The lymphocyte neutrophil index has high sensitivity, specificity and negative predictive value in the prediction of type 4a infarction. Its elevation six hours after the procedure is an independent predictor for this complication.


REFERENCES

  1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360. Disponible en: http://doi:10.1161/CIR.0000000000000350

  2. Anuario estadístico de salud 2019. Edición especial. Dirección Nacional de Registros Médicos y Estadísticas de Salud. La Habana, 2020. Disponible en: http://www.sld.cu/sitios/dne/

  3. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic Coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(3):407-47. Disponible en: http://doi:10.1093/eurheartj/ehz425

  4. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2019;40:87-165. Disponible en: http://doi:10.1093/eurheartj/ehy394

  5. Masoudi FA, Ponirakis A, Lemos JA, Jollis JG, Kremers M, Messenger JC, et al. Trends in U.S. cardiovascular care 2016 report from 4 ACC national cardiovascular data registries. J Am Coll Cardiol. 2017;69(11):1427-50. Disponible en: http://doi.org/10.10.1016/j.jacc.2016.12.005

  6. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio. Rev Esp Cardiol. 2019;72(1):72.e1-e27. Disponible en: http://doi.org/10.1016/j.recesp.2018.11.009

  7. Gregson J, Stone G.W, Ben-Yehuda O, Redfors B, Kandzari D.E, Morice MC, et al. Implications of alternative definitions of peri-procedural myocardial infarction after coronary revascularization. J Am Coll Cardiol. 2020;76:1609-21. Disponible en: http://doi.org/10.1016/j.jacc.2020.08.016

  8. Hara H, Serruys PW, Takahashi T, Kawashima H, Ono M, Gao C, et al. Impact of peri-procedural myocardial infarction on outcomes after revascularization. J Am Coll Cardiol. 2020;76:1622-39. Disponible en: http://doi.org/10.1016/j.jacc.2020.08.009

  9. Christensen MK, Huang H, Torp-Pedersen C, Trydal T, Ravkilde J. Incidence and impact on prognosis of periprocedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective followup study. BMC Cardiovascular Disorders. 2016;16:140. Disponible en: http://doi:10.1186/s12872-016-0293-4

  10. Kini AS, Yoshimura T, Vengrenyuk Y, Amirian J, Hasan Ch, Baber U, et al. Plaque morphology predictors of side branch occlusion after main vessel stenting in coronary bifurcation lesions. Jacc: cardiovascular interventions. 2016;9(8)684-86. Disponible en: http://doi:org/10.1016/j.jcin.2016.02.

  11. Huang S, Frangogiannis NG. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. British Journal of Pharmacology. 2018;175:1377-1400. Disponible en: http://doi:10.1111/bph.14155

  12. Angkananard T, Anothaisintawee T, Ingsathit A, McEvoy M, Silapat K, Attia J, et al. Mediation effect of neutrophil lymphocyte ratio on cardiometabolic risk factors and cardiovascular events. Scientific Reports. 2019;9:2618. Disponible en: http://doi:org/10.1038/s41598-019-39004-9

  13. Rodríguez S, Leyva AY, Aguilar JM, Collazo PM, Hernández E, Pérez JC, et al. Valor del índice neutrófilo-linfocitario en la predicción de la severidad de enfermedad arterial coronaria. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2020[acceso: 26/11/2020];26(1):1-6. Disponible en: Disponible en: http://www.revcardiologia.sld.cu/

  14. Rodríguez S, Leyva AY, Aguilar JM. Índice neutrófilo-linfocitario en la predicción de trombosis temprana del stent. Revista Argentina de Cardioangiología Intervencionista. 2020;11(1):17-20. Disponible en: http://doi.org/10.30567/RACI/202001/0017-0020

  15. Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Bellomo G, Marino P, et al. Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularization. Neth Heart J. 2016;24:462-74. Disponible en: http://doi:10.1007/s12471-016-0850-6

  16. Rodríguez S, Leyva AY, Aguilar JM, Barcelay FA, Tamargo TO. Índice neutrófilo-linfocitario en el diagnóstico de infarto de miocardio tipo 4a. Revista Argentina de Cardioangiología Intervencionista. 2020;11(3):126-31. Disponible en: http://doi.org/10.30567/RACI/202003/0126-0131

  17. Cutlip DE. Procedural myocardial infarction definitions everywhere, but not any that may fit. JACC. 2020;76(14):1640-3. Disponible en: http://doi.org/10.1016/j.jacc.2020.08.024

  18. Ndrepepa G, Colleran R, Braun S, Cassese S, Hieber J, Fusaro M, et al. High sensitivity troponin T and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol. 2016;68(21):2259-68. Disponible en: http//doi:10.1016/j.jacc.2016.08.059

  19. Thuijs D, Kappetein AP, Serruys PW, Mohr FW, Morice MC, Mack MJ, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with threevessel or left main coronary artery disease: 10- year follow-up of the multicentre randomized controlled SYNTAX trial. Lancet. 2019;394:1325-34. Disponible en: http//doi:10.1016/S0140-6736(19)31997-X

  20. Ben-Yehuda O, Chen S, Redfors B, McAndrew T, Crowley A, Kosmidou I, et al. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial. Eur Heart J. 2019;40:1930-41. Disponible en: http//doi:10.1093/eurheartj/ehz113

  21. Park DW, Kim YH, Yun SCh, Ahn JM, Lee JY, Kim WJ, et al. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. Eur Heart J. 2013;34:1662-69. Disponible en: http//doi:10.1093/eurheartj/eht048

  22. Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lynphocyte ratio? BMC Res Notes. 2017;10:12. Disponible en: http//doi:10.1186/s13104-016-2335-5

  23. Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Bio Med Research International. 2018. Article ID 2703518. Disponible en: http//doi.org/10.1155/2018/2703518

  24. Zhao L, Li Y, Xu T, Luan Y, Lv Q, Wang Y, et al. Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study. J Thorac Dis. 2020;12(10):5398-10. Disponible en: http//doi:10.21037/jtd-20-1605

  25. Zhang Q, Hu M, Sun J, Ma S. The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Scand Cardiovasc J. 2020;54(6):352-57. Disponible en: http//doi:10.1080/14017431.2020.178345

  26. Aloe R, Lippi G, Di Pietro M, Bonfanti L, Dipalo M, Comelli I, et al. Improved efficiency and cost reduction in the emergency department by replacing contemporary sensitive with high-sensitivity cardiac troponin immunoassay. Acta Biomed. 2019;90(4):614-20. Disponible en: https://doi: 10.23750/abm.v90i4.8769




2020     |     www.medigraphic.com